(2E)-1-(3-chlorophenyl)-3-(2,4-dichlorophenyl)prop-2-en-1-one, 95.0%, 10g

2-Chloro-5,8-dimethylquinoline-3-carbaldehyde, 97+%, 100g

3-(t-Butyldimethylsilyloxy)-2-fluorophenylboronic acid, 97%, 1g

N-Cbz-trans-1,4-cyclohexanediamine, 97.0%, 250mg

Recipiente de cristalización DURAN® con pico, 150 ml, 80 mm, 10 Unidad(es)

Benzo[d][1,3]dioxol-4-ylmethanamine, 95.0%, 5g

2,6-Dibromoanthraquinone, 95.0%, 1g

5-(Ethoxycarbonyl)-2-fluorophenylboronic Acid (contains varying amounts of Anhydride)1g

(4-((3-Methoxypropoxy)methyl)phenyl)boronic acid, 97%, 1g

Tetrahydro-1H-pyrrolo[1,2-c]imidazole-1,3(2H)-dione, 95.0%, 1g

(3-Cyano-4-(2,2,2-trifluoroethoxy)phenyl)boronic acid, 95%, 250mg

(3S,3'S)-3,3'-DI-TERT-BUTYL-2,2',3,3'-TETRAHYDRO-4,4'-BIBENZO[D][1,3]OXAPHOSPHOLE, 95%, 500mg

(4,6-Dichloropyridin-3yl)boronic acid, 95.0%, 250mg